Hannah Joseph Hospital IPO Details
Hannah Joseph Hospital IPO Summary
Hannah Joseph Hospital IPO opens for subscription on 22 Jan 2026 and closes on 28 Jan 2026.The IPO will be listed on BSE with the tentative listing date set for 02 Feb 2026.
Hannah Joseph Hospital IPO price band has been fixed at ₹67 – ₹70 per share. The face value is ₹10 per share with a lot size of 2000.
Hannah Joseph Hospital IPO total issue size comprises 60,00,000 shares (aggregating up to ₹42.00 Cr). This includes a fresh issue of 60,00,000 shares (aggregating up to ₹42.00 Cr). Pre-issue shareholding stands at 1,66,98,363, which will increase to 2,26,98,363 post-issue.
Hannah Joseph Hospital IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.
Hannah Joseph Hospital IPO Lot Size :Individual Minimum is 2 lots (4,000 shares) amounting to ₹280,000. Individual Maximum is 2 lots (4,000 shares) amounting to ₹280,000. SHNI Minimum is 3 lots (6,000 shares) amounting to ₹420,000. SHNI Maximum is 9 lots (18,000 shares) amounting to ₹1,260,000. BHNI Minimum is 10 lots (20,000 shares) amounting to ₹1,400,000.
The Lead Managers for Hannah Joseph Hospital IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Capitalsquare Advisors Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is CapitalSquare Financial Services Pvt Ltd. You can analyze their track record by checking the Market Maker Performance Summary report.
For detailed information, Refer to the Hannah Joseph Hospital Limited RHP.
Hannah Joseph Hospital IPO Details
Hannah Joseph Hospital IPO Subscription
Hannah Joseph Hospital IPO Application Wise Breakup
Hannah Joseph Hospital IPO Dates
- 22 Jan 2026Opening dateOpen
- 28 Jan 2026Closing dateClose
- 29 Jan 2026Allotment Date Allotment
- 30 Jan 2026Initiation of RefundsRefund
- 30 Jan 2026Credit of SharesCredit
- 02 Feb 2026Listing dateListing
Hannah Joseph Hospital IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 4000 | ₹280,000 |
| Individual Maximum | 2 | 4000 | ₹280,000 |
| SHNI Minimum | 3 | 6000 | ₹420,000 |
| SHNI Maximum | 9 | 18000 | ₹1,260,000 |
| BHNI Minimum | 10 | 20000 | ₹1,400,000 |
Hannah Joseph Hospital IPO Reservation
Promoter Holding
Documents
Hannah Joseph Hospital IPO Valuations
Hannah Joseph Hospital Financial Information
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 104.58 | 99.29 | 89.97 | 92.14 |
| Total Income | 42.75 | 77.90 | 63.63 | 54.90 |
| Profit After Tax | 5.12 | 7.21 | 4.07 | 1.01 |
| EBITDA | 11.65 | 20.52 | 17.98 | 16.38 |
| NET Worth | 53.22 | 48.93 | 43.93 | 34.15 |
| Reserves and Surplus | 40.36 | 35.24 | 29.02 | 18.20 |
| Total Borrowing | 31.64 | 33.58 | 31.39 | 42.95 |
| Amount in ₹ Crore | ||||
About Hannah Joseph Hospital IPO
Incorporated in 2011, Hannah Joseph Hospital Limited is a healthcare services provider offering comprehensive and specialised medical services across multiple clinical disciplines. The Company operates as a multi-specialty healthcare provider in Madurai, with a focus on delivering quality and affordable healthcare services.
The Company operates from a 2-acre hospital campus equipped with modern healthcare infrastructure, including central air-conditioning and a central water heating system. The hospital has a combined capacity of 150 beds, enabling it to serve a broad patient base across specialised medical services.
Hannah Joseph Hospital Limited focuses on key clinical specialities such as Neurology, Cardiology, Psychiatry, and Trauma Care. The Company emphasises adherence to global healthcare standards, a patient-centric approach, and responsiveness to the evolving needs of medical professionals, addressing the growing demand for reliable, high-quality, and affordable healthcare services.
The Company’s medical service offerings include:
Department of Neurosciences, comprising Neurology and Neurosurgery
Department of Cardio Sciences, comprising Cardiology
Department of Trauma Care, comprising Orthopaedics and Oral & Maxillofacial Surgery
Department of Psychiatry, comprising Psychiatry
As of November 30, 2025, the Company employed a total of 364 employees, including medical professionals, nursing staff, administrative personnel, and support teams, supporting its clinical and operational activities.
Strength Of Hannah Joseph Hospital IPO
- Founder led company supported by a highly experienced and professional management team.
- Company is reputed for providing quality health care and wellness.
- High consistency and success rates in handling complicated surgeries.
- Growth opportunities in existing facilities and diversification into new services.
- Ability to attract and retain high quality doctors, consultants and medical support staff.
Risk Of Hannah Joseph Hospital IPO
- We intend to utilize a portion of the Net Proceeds for setting up the Proposed Radiation Oncology Centre adjacent to the current hospital campus. We are yet to place orders for medical equipments and apply for requisite government approvals for the Proposed Radiation Oncology Centre. If we are unable to commission our Proposed Radiation Oncology Centre without time and cost overruns or unable to adhere to the schedule of implementation it may adversely affect our business, results of operations and financial conditions.
- We are required to obtain statutory and regulatory approvals, licenses or permits for our proposed radiation oncology centre. If we fail to obtain, maintain or renew our statutory and regulatory approvals or permits, our business, results of operations, financial condition, and cash flows could be adversely affected.
- There are outstanding legal proceedings involving our Company. Any adverse decisions could impact our net worth, profitability, cashflows and divert management time and attention and have an adverse effect on our business, prospects, results of operations and financial condition.
- Our Company did not open a separate bank account for private placements made in the past, utilized the proceeds from the issuance prior filing of Form PAS- 3, and issued private placement offer cum application letter before filing the Form MGT-14 with registrar and determined the relevant date within 30 days prior to the date of general meeting in violation of Section 42 of the Companies Act, 2013 and the rules made thereunder, which may have a material adverse effect on our business.
- There may have been certain instances of irregularities, discrepancies and non-compliances with respect to certain corporate actions taken by our Company in the past. Consequently, we may be subject to regulatory actions and penalties.
- Our company failed to obtain prior shareholder approval for a loan conversion option as required under Section 62(3) of the Companies Act, 2013 nor did it obtain the necessary valuation report for the same.
- We are dependent on a number of key personnel, including our Promoters and senior management, and the loss of or our inability to attract or retain such persons could adversely affect our business, financial condition, results of operations and cash flows.
- Our revenues are significantly dependent on our single hospital in Madurai. Any change in the economic or political circumstances in or around the areas of Madurai, could materially affect our business, financial condition and results of operations.
- We are dependent on certain field of specialty for a substantial portion of our revenue, i.e. neurosciences, interventional neuro-radiology, trauma services and radiology services. Any material impact on our earnings from these fields will impact our financial condition and results of operations significantly.
- Discontinuation of association by doctors and other healthcare professionals with our hospitals for any reason, and our inability to retain them may adversely affect our business and results of operations.
Objectives Hannah Joseph Hospital IPO
1. Funding of capital expenditure for establishing Radiation Oncology Centre
2. General Corporate Purpose
Company Contact Details
Hannah Joseph Hospital Limited
134,
Lake View Road K.K.Nagar,
Madurai 625020
Phone: 9524729594
Email: cs@hannahjosephhospital.com
Website: https://hannahjosephhospital.com/
Registrar Contact Details
Hannah Joseph Hospital FAQs
The Hannah Joseph Hospital IPO is a SME public issue comprising 6000000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹42.00 Cr. The issue price has been fixed at ₹70 per equity share, and the minimum application size is 2000 shares.
The IPO opens for subscription on 22 Jan 2026, and closes on 28 Jan 2026.
Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the BSE
As of now, the current GMP stands at ₹0 (0%).
Quick Links
Comments
